Showing results (61-70 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|July 5, 2022
Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II studyTiandong Kong, Lu Chen, Xiaoli Zhao, et al.Investigational New Drugs|January 1, 1985
Sequential studies on the role of mitoxantrone in the treatment of acute leukemiaH G Prentice, J Z Wimperis, G RobbinsInvestigational New Drugs|December 14, 2020
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastomaMohamed E M Saeed, Onat Kadioglu, Henry Johannes Greten, et al.Investigational New Drugs|January 3, 2021
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancersJ Wu, D Liu, M Offin, et al.Investigational New Drugs|January 4, 2021
Identification of chemoresistance-associated microRNAs and hub genes in breast cancer using bioinformatics analysisMing Wu, Yujie Zhao, Nanxi Peng, et al.Investigational New Drugs|January 1, 1987
5-MethyltetrahydrohomofolateP J O'Dwyer, B H Wagner, D F Hoth, et al.Investigational New Drugs|January 1, 1987
Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assayM G Daidone, R Silvestrini, N Zaffaroni, et al.Investigational New Drugs|January 1, 1987
New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drugT Skórski, M KawalecInvestigational New Drugs|January 1, 1985
Plasma kinetics and effects of 5,6-dihydro-5-azacytidine in mice and L1210 tumorD S Zaharko, J M Covey, J A KelleyInvestigational New Drugs|April 12, 2022
The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysisLi-Fang Meng, Jian-Feng Huang, Peng-Hui Luo, et al.Pageof 372